Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The host intestinal epithelium and gut ecosystem constitute a dynamic biological interface essential for nutrient absorption, metabolic regulation, and immune homeostasis [1]. The intestinal epithelium acts as a selective semi-permeable barrier, while the gut ecosystem, or microbiota, consists of a diverse community of bacteria, fungi, and viruses that interact with host cells [2]. This system is responsible for the primary defense against ingested pathogens and the maturation of the mucosal immune system [3]. Dysregulation of this system, often termed dysbiosis or barrier dysfunction, is a hallmark of various pathologies, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and metabolic syndromes like obesity [4]. Pharmacological interventions often target specific components within this niche, such as the mucosal barrier or microbial metabolites, to restore balance and prevent systemic inflammation [5]. Because it encompasses a vast array of cell types and species, it is characterized as a complex therapeutic environment rather than a discrete molecular target [6]. [1] https://www.nature.com/articles/nrgastro.2014.150 [2] https://pubmed.ncbi.nlm.nih.gov/24997038/ [3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337124/ [4] https://pmj.bmj.com/content/88/1037/145 [5] https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-016-0303-2 [6] https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-014-0189-7
Modulation of microbial composition, restoration of epithelial barrier integrity, suppression of mucosal inflammation, and competitive inhibition of pathogens.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host intestinal epithelium and gut ecosystem.